𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss Webster mouse

✍ Scribed by Stacy Branch; Bettina M. Francis; Cecil F. Brownie; Neil Chernoff


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
723 KB
Volume
112
Category
Article
ISSN
0300-483X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Differentially expressed genes associate
✍ Stacy Branch; Bettina M. Francis; Mitchell B. Rosen; Cecil F. Brownie; Gary A. H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

5-Aza-2'-deoxycytidine (d-AZA) inhibits methylation of DNA, a process that serves as an epigenetic regulator of gene expression. We have shown that d-AZA causes temporally related defects in mice. Gestational day (GD) 10 treatment induced severe long-bone defects of the hindlimb but not the forelimb

Analysis of genes upregulated by the dem
✍ Rintaro Mikata; Osamu Yokosuka; Kenichi Fukai; Fumio Imazeki; Makoto Arai; Motoh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 468 KB

## Abstract In gastric cancer, increasing numbers of genes have been reported to be silenced by aberrant methylation. However, global analysis of epigenetic inactivation in cancer cells has rarely been performed. For screening the genes upregulated by the demethylating agent 5‐aza‐2′‐deoxycytidine

The DNA demethylating agent 5-aza-2′-deo
✍ Atsushi Natsume; Toshihiko Wakabayashi; Kunio Tsujimura; Shinji Shimato; Motokaz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 835 KB

## Abstract Cancer/testis antigens (CTAs) are considered to be suitable targets for the immunotherapy of human malignancies. It has been demonstrated that in a variety of tumors, the expression of certain CTAs is activated __via__ the demethylation of their promoter CpG islands. In our study, we ha

Comparison of the effects of the chemopr
✍ Stewart Sale; Richard G. Tunstall; Ketan C. Ruparelia; Gerry A. Potter; William 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 306 KB 👁 1 views

## Abstract Naturally occurring molecules with putative cancer chemopreventive properties such as the phytoalexin resveratrol (3,5,4′‐trihydroxystilbene) are lead molecules that guide the design of novel agents with improved pharmacologic properties. The synthetic resveratrol analog 3,4,5,4′‐tetram